Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials
about
New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?Bivalirudin Anticoagulant Therapy With or Without Platelet Glycoprotein IIb/IIIa Inhibitors During Transcatheter Coronary Interventional Procedures: A Meta-AnalysisAn overview of PCI in the very elderlyCritical Appraisal of Bivalirudin versus Heparin for Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review.Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium.Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous Coronary Intervention.Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses.Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization : A real world experience.One-Year Mortality for Bivalirudin vs Heparins Plus Optional Glycoprotein IIb/IIIa Inhibitor Treatment Started in the Ambulance for ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the EUROMAX Randomized Clinical Trial.Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial.Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.Investigational new drugs for the treatment of acute coronary syndrome.Bivalirudin in percutaneous coronary intervention for chronic total occlusion: A single-center pilot study.Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-AnalysisDevelopment of bioanalytical assays for variegin, a peptide-based bivalent direct thrombin inhibitor.Bivalirudin versus heparin and provisional GP IIb/IIIa inhibitors in patients treated for ST-segment elevation myocardial infarctions: Comparison of outcomes in a "real-world" setting.Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications.Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.Gender-based outcomes of bivalirudin versus heparin in patients undergoing percutaneous coronary interventions: Meta-analysis of randomized controlled trials.The Rise and Fall of Anticoagulation with Bivalirudin During Percutaneous Coronary Interventions: A Review Article.Post-Procedural Bivalirudin Infusion Following Primary PCI to Reduce Stent Thrombosis.Antithrombotic therapy before, during and after emergency angioplasty for ST elevation myocardial infarction.Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database.Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?Incidence, predictors, and clinical outcomes of early stent thrombosis in acute myocardial infarction patients treated with primary percutaneous coronary angioplasty (insights from the University of Ottawa Heart Institute STEMI registry).The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.Comparison of antithrombotic agents during urgent percutaneous coronary intervention following thrombolytic therapy: A retrospective cohort study.Endovascular Treatment versus Best Medical Treatment in Patients with Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials.Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin. A position paper of the Acute Cardiovascular Care Association (ACCA) of the ESC.Bivalirudin in ST-segment-elevation myocardial infarction: for better or worse?Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key?
P2860
Q26765488-1D5381A1-8AF0-4197-9C5A-92E64568F1B3Q26798653-A2FAD22E-78EE-4B59-B750-73109A1B89F5Q35378992-1676917B-578F-4707-8B1E-341552CCD7CCQ35641465-51A69FB1-F129-4C0A-941A-6B7B47B57557Q36251279-596F2A95-B902-4970-97D8-7E602AFCBB36Q36322605-9EF9160E-A9E1-4B26-835C-9B3664883EF7Q36362768-D7A37887-A27B-41FB-886C-F2158088E5F2Q37030532-22B115ED-FE8F-492B-886A-42216957E844Q37212502-9BAC7E63-2DB6-4AFB-8224-78B75C6E28B5Q37329447-D62E4A73-FA4C-45B6-A563-EC68D2C95601Q37510674-20344C59-A1A1-4837-AEEF-6DE00B83F1B4Q38379744-C205AFA1-6EAE-46B4-81CD-645D5DF9D2F8Q38380117-3AB2DE63-247E-4769-B83F-F88165ABBBF8Q38423493-BF7FC89E-40B1-4C40-B8BC-FECE213A73CBQ38547727-5B4EE4B1-97B3-40B1-82B4-B542D0CF0E66Q38594609-301C8D4B-B4EE-42E7-9443-284AB8B8D101Q38647203-A939B501-B0C9-49B3-B2FC-6460973D481CQ38661324-3DB5CDE1-C7F3-4577-8743-5B1D12FCF34CQ38685685-172C6D03-8F01-40F8-8D0C-74E4965CF630Q38736998-54E56FCB-6390-4CFE-98F4-7579C677EFE4Q38829835-22B02344-DCCE-4068-9C9D-4901E5B9F9BAQ38850355-0D68CA13-B0E6-412D-923E-D824D4BB6656Q38879350-30D78553-49A7-4AE2-A922-1FD84A39CC23Q39096073-1BA14CAE-BF06-4CBF-9FAF-05D86C6E4512Q40046182-429F56B4-AE06-4ED6-9261-22244C8A2841Q40783270-EF536EC2-03C0-4AA1-A238-394840ECAEF1Q41716870-8C9BEA93-38CD-410C-AF12-5015DB13D729Q45047388-1292EFA5-1F35-4751-B080-6D9982015F56Q47109397-8A04B9F5-155D-4553-9C09-C813F83387A6Q47315444-6E8B1688-66CB-4574-90F6-875BFADAD21AQ48112185-9F82FBBD-99F7-4943-A3F0-B3ABC8ACDC93Q48266938-CB36691C-BE61-4793-93F5-E87A22032BDDQ52138744-34B87B2B-3D0B-4BC6-8D53-6821F9210936Q52862832-BE2B8D1E-A63D-488D-BE28-F412B167A0FAQ53633859-748125B4-D6FA-4297-B33B-4B1FD15990DFQ57551448-630C6FAB-BB6D-494C-980B-804C5E503B62
P2860
Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Bivalirudin versus heparin in ...... f randomised controlled trials
@ast
Bivalirudin versus heparin in ...... f randomised controlled trials
@en
Bivalirudin versus heparin in ...... f randomised controlled trials
@nl
type
label
Bivalirudin versus heparin in ...... f randomised controlled trials
@ast
Bivalirudin versus heparin in ...... f randomised controlled trials
@en
Bivalirudin versus heparin in ...... f randomised controlled trials
@nl
prefLabel
Bivalirudin versus heparin in ...... f randomised controlled trials
@ast
Bivalirudin versus heparin in ...... f randomised controlled trials
@en
Bivalirudin versus heparin in ...... f randomised controlled trials
@nl
P3181
P1433
P1476
Bivalirudin versus heparin in ...... f randomised controlled trials
@en
P2093
Marc S Sabatine
Matthew A Cavender
P304
P3181
P356
10.1016/S0140-6736(14)61216-2
P407
P577
2014-08-16T00:00:00Z